Cipla has submitted a copy of the Notice published on October 04, 2016 in Newspapers informing that the Company intends to apply to the Central Government under section 196 read with Schedule V and other applicable provisions of the Companies Act, 2013 for seeking its approval to the appointment of Umang Vohra as Managing Director of the Company designated as ‘Managing Director and Global Chief Executive Officer’ for a period of five years with effect from September 01, 2016
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1619.15 |
| Dr. Reddys Lab | 1324.00 |
| Cipla | 1300.80 |
| Zydus Lifesciences | 930.50 |
| Lupin | 2285.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: